Skip to content

SMART study - treatment breaks lower quality of life

Micronutrient supplement increases CD4 cell counts in patients on antiretroviral therapy

Large analysis shows benefits of starting treatment with efavirenz

Alphabet of prevention technologies expanding, but no 'magical solution'

Botswana’s adult HIV mortality rate falls since the rollout of free antiretroviral therapy

MK-0518 integrase inhibitor effective in treatment-naive patients

TNX-355, new entry inhibitor, effective in highly treatment-experienced patients

Maraviroc raises CD4 counts in patients with mixed-tropism virus, may offer value for highly treatment-experienced

Kaletra monotherapy as effective as triple therapy for at least 18 months